#METABOLOMICS WORKBENCH ramkhattri_20221222_111644 DATATRACK_ID:3670 STUDY_ID:ST002418 ANALYSIS_ID:AN003939
VERSION                          	1
CREATED_ON                       	01-04-2023
#PROJECT
PR:PROJECT_TITLE                 	Serum metabolomics and lipidomics profiling in iliac arteriovenous fistula
PR:PROJECT_TITLE                 	creation in clinical patients: part 1
PR:PROJECT_TYPE                  	Study of the serum metabolome in patients with end stage kidney disease before
PR:PROJECT_TYPE                  	and 6-weeks after iliac arteriovenous fistula creation via 1H NMR
PR:PROJECT_SUMMARY               	This project is focused on a longitudinal analysis of the small molecules
PR:PROJECT_SUMMARY               	metabolomes in end stage renal disease patients undergoing iliac arteriovenous
PR:PROJECT_SUMMARY               	fistula creation using solution state NMR spectroscopy. Blood samples were
PR:PROJECT_SUMMARY               	obtained prior to surgery and again 6-weeks after AVF creation.
PR:INSTITUTE                     	University of Florida
PR:DEPARTMENT                    	Applied Physiology and Kinesiology
PR:LABORATORY                    	Rm 42 and Rm 43
PR:LAST_NAME                     	Khattri
PR:FIRST_NAME                    	Ram
PR:ADDRESS                       	1864 Stadium RD, Gainesville, FL, 32611, USA
PR:EMAIL                         	rbk11@ufl.edu
PR:PHONE                         	3307856045
PR:FUNDING_SOURCE                	R01HL148597 and K23HL115673 (PI: Salvatore T. Scali)
PR:PROJECT_COMMENTS              	Study of the serum metabolome in patients with end stage kidney disease before
PR:PROJECT_COMMENTS              	and 6-weeks after iliac arteriovenous fistula creation via 1H NMR
PR:DOI                           	http://dx.doi.org/10.21228/M8K429
PR:CONTRIBUTORS                  	Ram B. Khattri, Kyoungrae Kim, Erik M. Anderson, Salvatore T. Scali, Terence E.
PR:CONTRIBUTORS                  	Ryan
#STUDY
ST:STUDY_TITLE                   	Serum metabolomics and lipidomics profiling in iliac arteriovenous fistula
ST:STUDY_TITLE                   	creation in clinical patients: part 2
ST:STUDY_TYPE                    	Study of the serum metabolome in patients with end stage kidney disease before
ST:STUDY_TYPE                    	and 6-weeks after iliac arteriovenous fistula creation via 1H NMR
ST:STUDY_SUMMARY                 	This project is focused on a longitudinal analysis of the small molecules
ST:STUDY_SUMMARY                 	metabolomes in end stage renal disease patients undergoing iliac arteriovenous
ST:STUDY_SUMMARY                 	fistula creation using solution state NMR spectroscopy. It was hypothesized that
ST:STUDY_SUMMARY                 	after 6-weeks of AVF creation, these patients would present with altered serum
ST:STUDY_SUMMARY                 	metabolite features.
ST:INSTITUTE                     	University of Florida
ST:DEPARTMENT                    	Applied Physiology and Kinesiology
ST:LABORATORY                    	Rm 42 and Rm 43
ST:LAST_NAME                     	Khattri
ST:FIRST_NAME                    	Ram
ST:ADDRESS                       	1864 Stadium RD, Gainesville, FL, 32611, USA
ST:EMAIL                         	rbk11@ufl.edu
ST:PHONE                         	3307856045
ST:SUBMIT_DATE                   	2022-12-22
#SUBJECT
SU:SUBJECT_TYPE                  	Human
SU:SUBJECT_SPECIES               	Homo sapiens
SU:TAXONOMY_ID                   	9606
SU:AGE_OR_AGE_RANGE              	67.47+/-13.50 years
SU:GENDER                        	Male and female
SU:HUMAN_RACE                    	Black(17), White(27), Other(1)
SU:HUMAN_ETHNICITY               	Black(17), White(27), Other(1)
SU:HUMAN_MEDICATIONS             	Allopurinol, Asprin,Atenolol, Atorvastatin calcium, calcitriol, Clopidogrel,
SU:HUMAN_MEDICATIONS             	Codeine, Gabapentin, Levothyroxine, Losartan, Alprostadil, Carbamide peroxide,
SU:HUMAN_MEDICATIONS             	Cinacalcet HCL, Diltiazem HCL, Exetimibe, Glipizide, Rosuvastatin CA, Valsartan
#SUBJECT_SAMPLE_FACTORS:         	SUBJECT(optional)[tab]SAMPLE[tab]FACTORS(NAME:VALUE pairs separated by |)[tab]Additional sample data
SUBJECT_SAMPLE_FACTORS           	-	Terence_AVF_33001-6wk_Org	Group:6-wk post op.	RAW_FILE_NAME=Terence_AVF_33001-6wk_Org
SUBJECT_SAMPLE_FACTORS           	-	Terence_AVF_33002-6wk_Org	Group:6-wk post op.	RAW_FILE_NAME=Terence_AVF_33002-6wk_Org
SUBJECT_SAMPLE_FACTORS           	-	Terence_AVF_33003-6wk_Org	Group:6-wk post op.	RAW_FILE_NAME=Terence_AVF_33003-6wk_Org
SUBJECT_SAMPLE_FACTORS           	-	Terence_AVF_33004-6wk_Org	Group:6-wk post op.	RAW_FILE_NAME=Terence_AVF_33004-6wk_Org
SUBJECT_SAMPLE_FACTORS           	-	Terence_AVF_33005-6wk_Org	Group:6-wk post op.	RAW_FILE_NAME=Terence_AVF_33005-6wk_Org
SUBJECT_SAMPLE_FACTORS           	-	Terence_AVF_33006-6wk_Org	Group:6-wk post op.	RAW_FILE_NAME=Terence_AVF_33006-6wk_Org
SUBJECT_SAMPLE_FACTORS           	-	Terence_AVF_33007-6wk_Org	Group:6-wk post op.	RAW_FILE_NAME=Terence_AVF_33007-6wk_Org
SUBJECT_SAMPLE_FACTORS           	-	Terence_AVF_33010-6wk_Org	Group:6-wk post op.	RAW_FILE_NAME=Terence_AVF_33010-6wk_Org
SUBJECT_SAMPLE_FACTORS           	-	Terence_AVF_33011-6wk_Org	Group:6-wk post op.	RAW_FILE_NAME=Terence_AVF_33011-6wk_Org
SUBJECT_SAMPLE_FACTORS           	-	Terence_AVF_33012-6wk_Org	Group:6-wk post op.	RAW_FILE_NAME=Terence_AVF_33012-6wk_Org
SUBJECT_SAMPLE_FACTORS           	-	Terence_AVF_33014-6wk_Org	Group:6-wk post op.	RAW_FILE_NAME=Terence_AVF_33014-6wk_Org
SUBJECT_SAMPLE_FACTORS           	-	Terence_AVF_33015-6wk_Org	Group:6-wk post op.	RAW_FILE_NAME=Terence_AVF_33015-6wk_Org
SUBJECT_SAMPLE_FACTORS           	-	Terence_AVF_33016-6wk_Org	Group:6-wk post op.	RAW_FILE_NAME=Terence_AVF_33016-6wk_Org
SUBJECT_SAMPLE_FACTORS           	-	Terence_AVF_33017-6wk_Org	Group:6-wk post op.	RAW_FILE_NAME=Terence_AVF_33017-6wk_Org
SUBJECT_SAMPLE_FACTORS           	-	Terence_AVF_33018-6wk_Org	Group:6-wk post op.	RAW_FILE_NAME=Terence_AVF_33018-6wk_Org
SUBJECT_SAMPLE_FACTORS           	-	Terence_AVF_33020-6wk_Org	Group:6-wk post op.	RAW_FILE_NAME=Terence_AVF_33020-6wk_Org
SUBJECT_SAMPLE_FACTORS           	-	Terence_AVF_33022-6wk_Org	Group:6-wk post op.	RAW_FILE_NAME=Terence_AVF_33022-6wk_Org
SUBJECT_SAMPLE_FACTORS           	-	Terence_AVF_33023-6wk_Org	Group:6-wk post op.	RAW_FILE_NAME=Terence_AVF_33023-6wk_Org
SUBJECT_SAMPLE_FACTORS           	-	Terence_AVF_33024-6wk_Org	Group:6-wk post op.	RAW_FILE_NAME=Terence_AVF_33024-6wk_Org
SUBJECT_SAMPLE_FACTORS           	-	Terence_AVF_33026-6wk_Org	Group:6-wk post op.	RAW_FILE_NAME=Terence_AVF_33026-6wk_Org
SUBJECT_SAMPLE_FACTORS           	-	Terence_AVF_33028-6wk_Org	Group:6-wk post op.	RAW_FILE_NAME=Terence_AVF_33028-6wk_Org
SUBJECT_SAMPLE_FACTORS           	-	Terence_AVF_33029-6Wk_Org	Group:6-wk post op.	RAW_FILE_NAME=Terence_AVF_33029-6Wk_Org
SUBJECT_SAMPLE_FACTORS           	-	Terence_AVF_33030-6wk_Org	Group:6-wk post op.	RAW_FILE_NAME=Terence_AVF_33030-6wk_Org
SUBJECT_SAMPLE_FACTORS           	-	Terence_AVF_33031-6wk_Org	Group:6-wk post op.	RAW_FILE_NAME=Terence_AVF_33031-6wk_Org
SUBJECT_SAMPLE_FACTORS           	-	Terence_AVF_33032-6wk_Org	Group:6-wk post op.	RAW_FILE_NAME=Terence_AVF_33032-6wk_Org
SUBJECT_SAMPLE_FACTORS           	-	Terence_AVF_33033-6wk_Org	Group:6-wk post op.	RAW_FILE_NAME=Terence_AVF_33033-6wk_Org
SUBJECT_SAMPLE_FACTORS           	-	Terence_AVF_33035-6wk_Org	Group:6-wk post op.	RAW_FILE_NAME=Terence_AVF_33035-6wk_Org
SUBJECT_SAMPLE_FACTORS           	-	Terence_AVF_33037-6wk_Org	Group:6-wk post op.	RAW_FILE_NAME=Terence_AVF_33037-6wk_Org
SUBJECT_SAMPLE_FACTORS           	-	Terence_AVF_33039-6wk_Org	Group:6-wk post op.	RAW_FILE_NAME=Terence_AVF_33039-6wk_Org
SUBJECT_SAMPLE_FACTORS           	-	Terence_AVF_33040-6wk_Org	Group:6-wk post op.	RAW_FILE_NAME=Terence_AVF_33040-6wk_Org
SUBJECT_SAMPLE_FACTORS           	-	Terence_AVF_33041-6wk_Org	Group:6-wk post op.	RAW_FILE_NAME=Terence_AVF_33041-6wk_Org
SUBJECT_SAMPLE_FACTORS           	-	Terence_AVF_33042-6wk_Org	Group:6-wk post op.	RAW_FILE_NAME=Terence_AVF_33042-6wk_Org
SUBJECT_SAMPLE_FACTORS           	-	Terence_AVF_33043-6wk_Org	Group:6-wk post op.	RAW_FILE_NAME=Terence_AVF_33043-6wk_Org
SUBJECT_SAMPLE_FACTORS           	-	Terence_AVF_33044-6wk_Org	Group:6-wk post op.	RAW_FILE_NAME=Terence_AVF_33044-6wk_Org
SUBJECT_SAMPLE_FACTORS           	-	Terence_AVF_33046-6wk_Org	Group:6-wk post op.	RAW_FILE_NAME=Terence_AVF_33046-6wk_Org
SUBJECT_SAMPLE_FACTORS           	-	Terence_AVF_33047-6wk_Org	Group:6-wk post op.	RAW_FILE_NAME=Terence_AVF_33047-6wk_Org
SUBJECT_SAMPLE_FACTORS           	-	Terence_AVF_33048-6wk_Org	Group:6-wk post op.	RAW_FILE_NAME=Terence_AVF_33048-6wk_Org
SUBJECT_SAMPLE_FACTORS           	-	Terence_AVF_33050-6wk_Org	Group:6-wk post op.	RAW_FILE_NAME=Terence_AVF_33050-6wk_Org
SUBJECT_SAMPLE_FACTORS           	-	Terence_AVF_33051-6wk_Org	Group:6-wk post op.	RAW_FILE_NAME=Terence_AVF_33051-6wk_Org
SUBJECT_SAMPLE_FACTORS           	-	Terence_AVF_33052-6wk_Org	Group:6-wk post op.	RAW_FILE_NAME=Terence_AVF_33052-6wk_Org
SUBJECT_SAMPLE_FACTORS           	-	Terence_AVF_33054-6wk_Org	Group:6-wk post op.	RAW_FILE_NAME=Terence_AVF_33054-6wk_Org
SUBJECT_SAMPLE_FACTORS           	-	Terence_AVF_33056-6wk_Org	Group:6-wk post op.	RAW_FILE_NAME=Terence_AVF_33056-6wk_Org
SUBJECT_SAMPLE_FACTORS           	-	Terence_AVF_33057-6wk_Org	Group:6-wk post op.	RAW_FILE_NAME=Terence_AVF_33057-6wk_Org
SUBJECT_SAMPLE_FACTORS           	-	Terence_AVF_33001-B_Org	Group:Baseline	RAW_FILE_NAME=Terence_AVF_33001-B_Org
SUBJECT_SAMPLE_FACTORS           	-	Terence_AVF_33002-B_Org	Group:Baseline	RAW_FILE_NAME=Terence_AVF_33002-B_Org
SUBJECT_SAMPLE_FACTORS           	-	Terence_AVF_33003-B_Org	Group:Baseline	RAW_FILE_NAME=Terence_AVF_33003-B_Org
SUBJECT_SAMPLE_FACTORS           	-	Terence_AVF_33004-B_Org	Group:Baseline	RAW_FILE_NAME=Terence_AVF_33004-B_Org
SUBJECT_SAMPLE_FACTORS           	-	Terence_AVF_33005-B_Org	Group:Baseline	RAW_FILE_NAME=Terence_AVF_33005-B_Org
SUBJECT_SAMPLE_FACTORS           	-	Terence_AVF_33006-B_Org	Group:Baseline	RAW_FILE_NAME=Terence_AVF_33006-B_Org
SUBJECT_SAMPLE_FACTORS           	-	Terence_AVF_33007-B_Org	Group:Baseline	RAW_FILE_NAME=Terence_AVF_33007-B_Org
SUBJECT_SAMPLE_FACTORS           	-	Terence_AVF_33010-B_Org	Group:Baseline	RAW_FILE_NAME=Terence_AVF_33010-B_Org
SUBJECT_SAMPLE_FACTORS           	-	Terence_AVF_33012-B_Org	Group:Baseline	RAW_FILE_NAME=Terence_AVF_33012-B_Org
SUBJECT_SAMPLE_FACTORS           	-	Terence_AVF_33014-B_Org	Group:Baseline	RAW_FILE_NAME=Terence_AVF_33014-B_Org
SUBJECT_SAMPLE_FACTORS           	-	Terence_AVF_33015-B_Org	Group:Baseline	RAW_FILE_NAME=Terence_AVF_33015-B_Org
SUBJECT_SAMPLE_FACTORS           	-	Terence_AVF_33016-B_Org	Group:Baseline	RAW_FILE_NAME=Terence_AVF_33016-B_Org
SUBJECT_SAMPLE_FACTORS           	-	Terence_AVF_33017-B_Org	Group:Baseline	RAW_FILE_NAME=Terence_AVF_33017-B_Org
SUBJECT_SAMPLE_FACTORS           	-	Terence_AVF_33018-B_Org	Group:Baseline	RAW_FILE_NAME=Terence_AVF_33018-B_Org
SUBJECT_SAMPLE_FACTORS           	-	Terence_AVF_33020-B_Org	Group:Baseline	RAW_FILE_NAME=Terence_AVF_33020-B_Org
SUBJECT_SAMPLE_FACTORS           	-	Terence_AVF_33022-B_Org	Group:Baseline	RAW_FILE_NAME=Terence_AVF_33022-B_Org
SUBJECT_SAMPLE_FACTORS           	-	Terence_AVF_33023-B_Org	Group:Baseline	RAW_FILE_NAME=Terence_AVF_33023-B_Org
SUBJECT_SAMPLE_FACTORS           	-	Terence_AVF_33024-B_Org	Group:Baseline	RAW_FILE_NAME=Terence_AVF_33024-B_Org
SUBJECT_SAMPLE_FACTORS           	-	Terence_AVF_33026-B_Org	Group:Baseline	RAW_FILE_NAME=Terence_AVF_33026-B_Org
SUBJECT_SAMPLE_FACTORS           	-	Terence_AVF_33028-B_Org	Group:Baseline	RAW_FILE_NAME=Terence_AVF_33028-B_Org
SUBJECT_SAMPLE_FACTORS           	-	Terence_AVF_33029-B_Org	Group:Baseline	RAW_FILE_NAME=Terence_AVF_33029-B_Org
SUBJECT_SAMPLE_FACTORS           	-	Terence_AVF_33030-B_Org	Group:Baseline	RAW_FILE_NAME=Terence_AVF_33030-B_Org
SUBJECT_SAMPLE_FACTORS           	-	Terence_AVF_33031-B_Org	Group:Baseline	RAW_FILE_NAME=Terence_AVF_33031-B_Org
SUBJECT_SAMPLE_FACTORS           	-	Terence_AVF_33032-B_Org	Group:Baseline	RAW_FILE_NAME=Terence_AVF_33032-B_Org
SUBJECT_SAMPLE_FACTORS           	-	Terence_AVF_33033-B_Org	Group:Baseline	RAW_FILE_NAME=Terence_AVF_33033-B_Org
SUBJECT_SAMPLE_FACTORS           	-	Terence_AVF_33035-B_Org	Group:Baseline	RAW_FILE_NAME=Terence_AVF_33035-B_Org
SUBJECT_SAMPLE_FACTORS           	-	Terence_AVF_33037-B_Org	Group:Baseline	RAW_FILE_NAME=Terence_AVF_33037-B_Org
SUBJECT_SAMPLE_FACTORS           	-	Terence_AVF_33038-B_Org	Group:Baseline	RAW_FILE_NAME=Terence_AVF_33038-B_Org
SUBJECT_SAMPLE_FACTORS           	-	Terence_AVF_33039-B_Org	Group:Baseline	RAW_FILE_NAME=Terence_AVF_33039-B_Org
SUBJECT_SAMPLE_FACTORS           	-	Terence_AVF_33040-B_Org	Group:Baseline	RAW_FILE_NAME=Terence_AVF_33040-B_Org
SUBJECT_SAMPLE_FACTORS           	-	Terence_AVF_33041-B_Org	Group:Baseline	RAW_FILE_NAME=Terence_AVF_33041-B_Org
SUBJECT_SAMPLE_FACTORS           	-	Terence_AVF_33042-B_Org	Group:Baseline	RAW_FILE_NAME=Terence_AVF_33042-B_Org
SUBJECT_SAMPLE_FACTORS           	-	Terence_AVF_33043-B_Org	Group:Baseline	RAW_FILE_NAME=Terence_AVF_33043-B_Org
SUBJECT_SAMPLE_FACTORS           	-	Terence_AVF_33044-B_Org	Group:Baseline	RAW_FILE_NAME=Terence_AVF_33044-B_Org
SUBJECT_SAMPLE_FACTORS           	-	Terence_AVF_33046-B_Org	Group:Baseline	RAW_FILE_NAME=Terence_AVF_33046-B_Org
SUBJECT_SAMPLE_FACTORS           	-	Terence_AVF_33047-B_Org	Group:Baseline	RAW_FILE_NAME=Terence_AVF_33047-B_Org
SUBJECT_SAMPLE_FACTORS           	-	Terence_AVF_33048-B_Org	Group:Baseline	RAW_FILE_NAME=Terence_AVF_33048-B_Org
SUBJECT_SAMPLE_FACTORS           	-	Terence_AVF_33050-B_Org	Group:Baseline	RAW_FILE_NAME=Terence_AVF_33050-B_Org
SUBJECT_SAMPLE_FACTORS           	-	Terence_AVF_33051-B_Org	Group:Baseline	RAW_FILE_NAME=Terence_AVF_33051-B_Org
SUBJECT_SAMPLE_FACTORS           	-	Terence_AVF_33052-B_Org	Group:Baseline	RAW_FILE_NAME=Terence_AVF_33052-B_Org
SUBJECT_SAMPLE_FACTORS           	-	Terence_AVF_33053-B_Org	Group:Baseline	RAW_FILE_NAME=Terence_AVF_33053-B_Org
SUBJECT_SAMPLE_FACTORS           	-	Terence_AVF_33054-B_Org	Group:Baseline	RAW_FILE_NAME=Terence_AVF_33054-B_Org
SUBJECT_SAMPLE_FACTORS           	-	Terence_AVF_33056-B_Org	Group:Baseline	RAW_FILE_NAME=Terence_AVF_33056-B_Org
#COLLECTION
CO:COLLECTION_SUMMARY            	Institutional review board (IRB) of the University of Florida reviewed and
CO:COLLECTION_SUMMARY            	approved this study. All human subjects included in this study were fully
CO:COLLECTION_SUMMARY            	informed about the study, and informed consent were obtained from each of them
CO:COLLECTION_SUMMARY            	(IRB#140-2013, IRB#556-2009). Blood samples from ESKD patients were collected at
CO:COLLECTION_SUMMARY            	different time points: baseline (pre-operation) and 6-weeks post-op from fistula
CO:COLLECTION_SUMMARY            	creation.
CO:COLLECTION_PROTOCOL_FILENAME  	AVF-NMR_Lipid_Phase_Procedures.docx
CO:SAMPLE_TYPE                   	Blood (serum)
CO:COLLECTION_METHOD             	Serum samples were collected from the patients. The samples were let sit at room
CO:COLLECTION_METHOD             	temperature for ~45 minutes. Later, the samples were centrifuged for 15 minutes
CO:COLLECTION_METHOD             	maintaining 2180-rpm speed at 4 oC with brake on. The supernatant from each
CO:COLLECTION_METHOD             	sample was transfered into a new 15 mL tube and furthermore, aliquoted into a
CO:COLLECTION_METHOD             	vial (250 uL in each vial). All of the serum samples were stored at -80 oC until
CO:COLLECTION_METHOD             	analysis.
CO:STORAGE_CONDITIONS            	-80℃
CO:COLLECTION_VIALS              	cryovials
CO:STORAGE_VIALS                 	cryovials
#TREATMENT
TR:TREATMENT_SUMMARY             	Metabolomic profile of serum from end stage kidney disease before and 6-week
TR:TREATMENT_SUMMARY             	after AVF surgery were evaluated. After 6-week of post op., ESKD patients
TR:TREATMENT_SUMMARY             	exhibited difference in few small-molecule environment. A total of 45 ESKD
TR:TREATMENT_SUMMARY             	patients were included in this study, with a life expectancy greater than or
TR:TREATMENT_SUMMARY             	equal to 9 months (in the period 2012-2015). These patients were evaluated for
TR:TREATMENT_SUMMARY             	demographics, comorbidities, hand dominance and prior access history before and
TR:TREATMENT_SUMMARY             	6 weeks post operation.
TR:HUMAN_FASTING                 	non-fasted
TR:HUMAN_ENDP_CLINICAL_SIGNS     	N/A
#SAMPLEPREP
SP:SAMPLEPREP_SUMMARY            	Serum samples are associated with binding of residual proteins with DSS signal,
SP:SAMPLEPREP_SUMMARY            	resulting broaden DSS peak. The presence of the residual proteins, even after
SP:SAMPLEPREP_SUMMARY            	performing modified FOLCH extraction, was observed for serum samples, making it
SP:SAMPLEPREP_SUMMARY            	un-reliable for quantitative purpose. In this study, we coupled two extraction
SP:SAMPLEPREP_SUMMARY            	protocols to extract metabolites from the serum samples. Modified FOLCH
SP:SAMPLEPREP_SUMMARY            	extraction was performed as a first step to separate out water-soluble and
SP:SAMPLEPREP_SUMMARY            	lipid-soluble metabolites/compounds. Furthermore, acetonitrile:isopropanol:water
SP:SAMPLEPREP_SUMMARY            	(3:3:2 vol/vol/vol) extraction was performed on aqueous phase samples that we
SP:SAMPLEPREP_SUMMARY            	obtained from modified FOLCH extraction.
SP:SAMPLEPREP_PROTOCOL_FILENAME  	AVF-NMR_Lipid_Phase_Procedures.docx
SP:PROCESSING_METHOD             	Lyophilization and Homogenization
SP:PROCESSING_STORAGE_CONDITIONS 	-80℃
SP:EXTRACTION_METHOD             	Modified FOLCH extraction for lipid phase samples
SP:EXTRACT_STORAGE               	-80℃
SP:SAMPLE_RESUSPENSION           	In 700 microliter of CDCl3 with 10 mM of pyrazine as internal standard for lipid
SP:SAMPLE_RESUSPENSION           	phase samples
SP:SAMPLE_SPIKING                	10 mM of TSP for urine samples
#CHROMATOGRAPHY
#ANALYSIS
AN:LABORATORY_NAME               	McKnight Brain Institute
AN:ANALYSIS_TYPE                 	NMR
AN:ANALYSIS_PROTOCOL_FILE        	AVF-NMR_Lipid_Phase_Procedures.docx
AN:ACQUISITION_DATE              	08/02/2022
AN:SOFTWARE_VERSION              	Topspin
AN:OPERATOR_NAME                 	Ram Khattri
AN:DETECTOR_TYPE                 	Bruker 600 MHz
AN:DATA_FORMAT                   	fid, 1r
#NMR
NM:INSTRUMENT_NAME               	Bruker 600 MHz
NM:INSTRUMENT_TYPE               	FT-NMR
NM:NMR_EXPERIMENT_TYPE           	1D-1H
NM:FIELD_FREQUENCY_LOCK          	CDCl3
NM:STANDARD_CONCENTRATION        	10 mM TSP
NM:SPECTROMETER_FREQUENCY        	600 MHz
NM:NMR_PROBE                     	5mm TXI CryoProbe
NM:NMR_SOLVENT                   	700 uL of CDCl3 with 10 mM pyrazine
NM:NMR_TUBE_SIZE                 	5 mm O.D.
NM:SHIMMING_METHOD               	Topshim
NM:PULSE_SEQUENCE                	noesy1d
NM:WATER_SUPPRESSION             	none
NM:PULSE_WIDTH                   	90-degree
NM:RECEIVER_GAIN                 	106.7
NM:CHEMICAL_SHIFT_REF_CPD        	TPS
NM:TEMPERATURE                   	298.2 oK
NM:NUMBER_OF_SCANS               	128
NM:DUMMY_SCANS                   	8
NM:ACQUISITION_TIME              	4s
NM:RELAXATION_DELAY              	1s
NM:SPECTRAL_WIDTH                	9578.5
NM:NUM_DATA_POINTS_ACQUIRED      	38313
NM:REAL_DATA_POINTS              	65536
NM:LINE_BROADENING               	0.22 Hz
NM:ZERO_FILLING                  	65,536 points
NM:APODIZATION                   	Exponential
NM:BASELINE_CORRECTION_METHOD    	Spline
NM:CHEMICAL_SHIFT_REF_STD        	7.26 ppm for CDCl3
NM:BINNED_INCREMENT              	NA
NM:BINNED_DATA_PROTOCOL_FILE     	NA
NM:BINNED_DATA_EXCLUDED_RANGE    	NA
#NMR_METABOLITE_DATA
NMR_METABOLITE_DATA:UNITS        	Peak intensity
NMR_METABOLITE_DATA_START
Samples	Terence_AVF_33001-6wk_Org	Terence_AVF_33002-6wk_Org	Terence_AVF_33003-6wk_Org	Terence_AVF_33004-6wk_Org	Terence_AVF_33005-6wk_Org	Terence_AVF_33006-6wk_Org	Terence_AVF_33007-6wk_Org	Terence_AVF_33010-6wk_Org	Terence_AVF_33011-6wk_Org	Terence_AVF_33012-6wk_Org	Terence_AVF_33014-6wk_Org	Terence_AVF_33015-6wk_Org	Terence_AVF_33016-6wk_Org	Terence_AVF_33017-6wk_Org	Terence_AVF_33018-6wk_Org	Terence_AVF_33020-6wk_Org	Terence_AVF_33022-6wk_Org	Terence_AVF_33023-6wk_Org	Terence_AVF_33024-6wk_Org	Terence_AVF_33026-6wk_Org	Terence_AVF_33028-6wk_Org	Terence_AVF_33029-6Wk_Org	Terence_AVF_33030-6wk_Org	Terence_AVF_33031-6wk_Org	Terence_AVF_33032-6wk_Org	Terence_AVF_33033-6wk_Org	Terence_AVF_33035-6wk_Org	Terence_AVF_33037-6wk_Org	Terence_AVF_33039-6wk_Org	Terence_AVF_33040-6wk_Org	Terence_AVF_33041-6wk_Org	Terence_AVF_33042-6wk_Org	Terence_AVF_33043-6wk_Org	Terence_AVF_33044-6wk_Org	Terence_AVF_33046-6wk_Org	Terence_AVF_33047-6wk_Org	Terence_AVF_33048-6wk_Org	Terence_AVF_33050-6wk_Org	Terence_AVF_33051-6wk_Org	Terence_AVF_33052-6wk_Org	Terence_AVF_33054-6wk_Org	Terence_AVF_33056-6wk_Org	Terence_AVF_33057-6wk_Org	Terence_AVF_33001-B_Org	Terence_AVF_33002-B_Org	Terence_AVF_33003-B_Org	Terence_AVF_33004-B_Org	Terence_AVF_33005-B_Org	Terence_AVF_33006-B_Org	Terence_AVF_33007-B_Org	Terence_AVF_33010-B_Org	Terence_AVF_33012-B_Org	Terence_AVF_33014-B_Org	Terence_AVF_33015-B_Org	Terence_AVF_33016-B_Org	Terence_AVF_33017-B_Org	Terence_AVF_33018-B_Org	Terence_AVF_33020-B_Org	Terence_AVF_33022-B_Org	Terence_AVF_33023-B_Org	Terence_AVF_33024-B_Org	Terence_AVF_33026-B_Org	Terence_AVF_33028-B_Org	Terence_AVF_33029-B_Org	Terence_AVF_33030-B_Org	Terence_AVF_33031-B_Org	Terence_AVF_33032-B_Org	Terence_AVF_33033-B_Org	Terence_AVF_33035-B_Org	Terence_AVF_33037-B_Org	Terence_AVF_33038-B_Org	Terence_AVF_33039-B_Org	Terence_AVF_33040-B_Org	Terence_AVF_33041-B_Org	Terence_AVF_33042-B_Org	Terence_AVF_33043-B_Org	Terence_AVF_33044-B_Org	Terence_AVF_33046-B_Org	Terence_AVF_33047-B_Org	Terence_AVF_33048-B_Org	Terence_AVF_33050-B_Org	Terence_AVF_33051-B_Org	Terence_AVF_33052-B_Org	Terence_AVF_33053-B_Org	Terence_AVF_33054-B_Org	Terence_AVF_33056-B_Org
Factors	Group:6-wk post op.	Group:6-wk post op.	Group:6-wk post op.	Group:6-wk post op.	Group:6-wk post op.	Group:6-wk post op.	Group:6-wk post op.	Group:6-wk post op.	Group:6-wk post op.	Group:6-wk post op.	Group:6-wk post op.	Group:6-wk post op.	Group:6-wk post op.	Group:6-wk post op.	Group:6-wk post op.	Group:6-wk post op.	Group:6-wk post op.	Group:6-wk post op.	Group:6-wk post op.	Group:6-wk post op.	Group:6-wk post op.	Group:6-wk post op.	Group:6-wk post op.	Group:6-wk post op.	Group:6-wk post op.	Group:6-wk post op.	Group:6-wk post op.	Group:6-wk post op.	Group:6-wk post op.	Group:6-wk post op.	Group:6-wk post op.	Group:6-wk post op.	Group:6-wk post op.	Group:6-wk post op.	Group:6-wk post op.	Group:6-wk post op.	Group:6-wk post op.	Group:6-wk post op.	Group:6-wk post op.	Group:6-wk post op.	Group:6-wk post op.	Group:6-wk post op.	Group:6-wk post op.	Group:Baseline	Group:Baseline	Group:Baseline	Group:Baseline	Group:Baseline	Group:Baseline	Group:Baseline	Group:Baseline	Group:Baseline	Group:Baseline	Group:Baseline	Group:Baseline	Group:Baseline	Group:Baseline	Group:Baseline	Group:Baseline	Group:Baseline	Group:Baseline	Group:Baseline	Group:Baseline	Group:Baseline	Group:Baseline	Group:Baseline	Group:Baseline	Group:Baseline	Group:Baseline	Group:Baseline	Group:Baseline	Group:Baseline	Group:Baseline	Group:Baseline	Group:Baseline	Group:Baseline	Group:Baseline	Group:Baseline	Group:Baseline	Group:Baseline	Group:Baseline	Group:Baseline	Group:Baseline	Group:Baseline	Group:Baseline	Group:Baseline	
1CH phospholipids+TG	3.6340	1.0504	2.5547	1.9238	1.6468	1.9531	1.8846	2.6215	3.0666	1.7291	1.6234	2.2769	1.6390	2.2784	2.3215	1.3817	2.5144	1.6924	1.5293	2.8150	1.3052	4.7199	2.2045	1.6477	4.1605	2.4413	2.2899	1.4383	2.2370	1.3465	1.4449	1.5650	2.7483	2.3997	3.0470	1.4668	2.2819	2.7214	1.0097	2.0549	1.5053	2.5450	3.3122	4.0734	1.7722	2.4618	2.3607	1.2111	1.2220	0.8959	2.1398	3.7806	2.4896	1.3869	2.2172	1.9423	2.2847	1.0955	1.5076	2.0405	1.3312	2.3100	0.9851	3.6098	1.7992	1.2853	4.1289	2.7000	2.3272	2.5574	2.0672	1.3115	1.6988	3.4885	3.0925	2.5159	2.0687	3.8112	2.1085	1.6483	2.0030	1.4860	1.4439	1.4252	2.7128	2.4037
C18-CH3 chol	12.5077	4.7347	8.0799	6.3484	4.6320	8.0920	6.3740	10.1213	10.7043	6.7436	5.7629	8.1198	7.3950	7.6573	8.3026	5.5676	8.1446	5.7464	4.9520	10.3317	4.5580	17.1132	8.3717	6.5757	15.1895	8.9606	8.1435	4.9101	7.9968	5.5929	6.6758	5.5845	9.8864	7.9038	11.6247	6.8757	8.3605	11.1018	3.6157	7.4984	5.0218	9.7072	11.4369	15.8251	5.8828	8.5930	8.1012	4.6036	5.0928	3.7284	8.2490	13.6949	8.7032	5.5189	7.4804	6.7636	6.2050	4.6853	7.3193	7.6294	5.1950	10.6606	3.5650	12.8769	7.1189	5.6607	14.6591	10.2521	8.8121	6.1257	8.0971	5.2437	6.6716	10.0709	11.2880	8.5397	7.6779	14.7444	7.7412	7.2398	6.0862	5.3459	4.0012	4.6147	9.8837	8.1668
C19-CH3 Esterified Chol	5.2210	1.9762	2.9955	2.7185	1.8004	3.2815	2.5781	4.4210	4.2158	2.8235	2.2964	3.1724	3.1202	3.1736	3.3082	2.4579	3.6714	2.3207	2.0933	4.0383	1.7430	6.4865	3.6658	2.6182	5.4522	3.5436	3.3106	2.1278	3.2327	2.2917	2.9982	2.2563	3.7489	3.1376	4.3869	3.1878	3.8517	4.6729	1.9671	3.1763	2.0144	4.0784	4.4644	6.3928	2.3732	3.3407	2.9855	1.9774	2.1750	1.6700	3.9346	5.4712	3.5131	2.3303	2.9758	2.8395	2.4584	2.1338	3.4019	3.2765	2.2887	4.1005	1.6495	5.2005	3.0821	2.5610	5.4245	4.3853	3.7620	3.5080	3.2041	2.1394	2.9195	4.0469	4.3506	3.4360	3.1345	5.4937	3.8945	3.4682	2.6151	2.4894	1.6633	1.7594	4.1345	3.0680
C19-CH3 free Chol	9.3086	3.7408	6.4504	4.7130	3.7783	6.3628	5.1493	7.3333	8.5578	5.1017	4.6935	6.5610	5.6454	6.0609	6.6730	4.2682	5.7771	4.6772	3.9891	8.3320	3.8481	13.8154	6.3794	5.2870	12.6483	7.2064	6.5041	3.8610	6.4851	4.6076	5.0885	4.6330	8.2494	6.2947	9.4127	5.0201	6.2925	8.5653	2.4265	5.7905	4.0826	7.2900	9.0116	12.2912	4.6497	6.9765	6.7856	3.6599	4.0805	2.9949	6.0090	10.9292	6.9648	4.4678	6.1672	5.4171	5.1793	3.6501	5.2254	6.0036	4.2035	8.6119	2.8835	10.2550	5.6284	4.1477	12.2021	7.9591	6.6457	6.4003	6.4006	4.2634	5.0993	7.7241	9.0829	6.8011	6.1239	12.0564	5.2477	5.1518	4.6110	4.0037	3.1118	3.8601	7.6472	6.7661
CH2CH2CH2(CH2)-fatty acyl chains	183.4818	76.9600	79.0586	89.0360	53.8293	84.2568	91.3179	181.5618	127.0096	105.6444	62.7796	84.9128	77.4549	162.8190	131.2246	67.4817	165.4129	82.9812	77.9015	169.6534	48.3226	211.1317	110.6078	70.7619	143.8135	88.8066	110.7417	101.6887	70.7312	85.9566	105.5147	64.6095	131.2462	68.1998	119.8466	168.3997	223.2615	180.4875	71.0306	100.3171	54.4469	112.1759	146.5299	211.3227	73.2959	97.8866	74.2041	68.0855	72.4754	58.8490	180.8647	144.3700	92.9999	57.3482	84.4526	70.4415	88.3694	50.0202	142.6131	120.1602	82.0658	140.3011	38.4308	172.5078	107.1726	94.0042	146.9914	111.5847	127.5146	90.7343	77.1754	87.4783	81.2052	99.4722	138.4194	135.1929	67.3150	133.0243	231.7487	193.0934	135.9101	100.7439	64.7065	65.2629	123.0657	80.0738
CH2-CH=CH-CH2-alpha18:1	19.9357	7.6809	8.9176	10.7202	7.2999	9.0300	9.6360	20.7376	13.9490	12.1949	6.6574	8.8920	8.0343	15.4239	15.7271	6.9390	20.5401	8.8754	7.8858	17.0452	4.8583	21.0363	11.7861	7.3298	17.0916	8.1975	12.4703	10.4609	8.0438	8.3892	10.8008	7.0364	13.2184	8.1600	12.1260	19.3099	23.7632	17.7238	8.0822	11.3706	6.3875	12.7136	15.0205	21.1264	8.5640	10.6791	8.0311	7.4060	7.9926	6.0308	18.4112	14.9249	10.0257	5.9502	8.8079	7.7927	10.0818	5.3384	17.2975	14.0327	8.3442	14.4641	4.2886	17.4194	11.6599	9.3889	17.9579	11.5702	15.3618	10.7287	8.7969	9.7822	8.4043	14.8964	15.6864	15.8315	7.3336	12.9632	27.3535	21.2906	14.9116	11.7264	6.6409	7.2200	13.9643	7.7438
CH2-CH=CH-CH2-alpha18:2or20:4	21.4979	7.4535	9.0302	8.0726	4.9985	7.8046	8.9367	17.5799	13.3843	9.1617	6.6587	9.5769	7.9530	15.7842	11.7039	7.0036	14.9676	8.3466	8.0479	17.4850	5.1011	25.8563	11.5025	7.4193	15.4691	11.8201	10.0144	9.3918	7.9155	8.2756	9.4410	6.6497	13.5611	7.5037	14.1128	13.8069	20.9171	21.3966	6.6949	10.3471	6.3973	11.4973	18.0926	25.9293	8.4455	10.6159	8.4038	6.6139	6.8590	5.6174	20.3828	17.0197	10.3976	5.7054	9.7067	7.5502	10.3503	5.1413	12.0353	10.7790	8.4638	14.7400	3.8021	20.6238	10.0937	6.9519	14.3119	12.6152	12.0655	9.7525	8.2448	8.2565	8.7052	13.1040	14.0092	14.4809	8.3816	17.8704	21.5503	18.2580	13.1786	9.3506	6.4200	6.5775	12.5650	10.5300
CH2COO-alpha	34.4351	13.1555	15.6145	16.0676	10.8794	15.2546	16.7904	32.5425	24.0823	19.7517	11.8080	16.2513	14.5332	29.5662	23.3513	11.8338	29.6564	14.8082	13.5782	30.9954	8.7030	39.9707	20.3229	13.2989	28.6697	17.5190	20.6946	17.0546	13.9268	14.6549	18.3324	11.0803	24.6804	13.8957	23.5241	28.4968	37.9924	32.1334	11.7002	18.8640	10.8125	22.0663	28.1065	39.6925	13.9426	18.4300	15.1443	12.0885	12.3597	9.7719	30.8473	28.6702	18.2961	10.1155	16.0218	13.6983	16.8952	8.5698	24.1548	21.1002	13.8465	25.2401	7.0430	31.7136	18.4371	15.1974	28.4195	21.5059	23.5888	17.4091	14.7494	14.6623	14.8653	20.6219	26.3281	23.9690	13.7253	26.6162	38.4101	32.3727	22.8566	17.4568	11.1529	11.3102	23.4499	15.6506
CH2n aliphatic chains	85.9032	40.9650	40.3588	45.1080	27.4732	43.0055	47.4440	93.2095	60.4758	64.7081	31.2690	42.0344	42.1471	95.5834	59.5963	34.6858	88.8602	39.5740	38.6562	81.3775	23.0560	92.3022	55.4401	37.8224	72.4043	39.8722	57.2273	49.8722	31.3319	42.7997	52.8956	25.8658	69.6852	33.8130	56.0654	88.5960	113.0618	84.4159	35.4744	50.8911	23.6542	63.4991	71.0672	99.7919	38.0012	46.6357	36.9862	36.1723	35.9506	29.9592	81.6727	69.0519	49.0908	30.2546	39.5734	35.8671	37.7981	24.9541	76.7986	59.4926	42.4123	69.9709	18.5004	77.0531	51.6514	47.2898	74.3168	53.1172	66.6877	45.3934	36.4342	40.4369	41.5584	42.7397	70.0746	57.4547	32.0765	60.7116	107.4509	96.4884	61.4867	49.3748	29.0758	29.0116	63.7088	36.6647
CH2_TG1	5.9971	2.3491	1.6328	2.5861	1.4131	1.7783	2.7873	6.2189	3.4489	3.5068	1.5157	1.9170	1.6431	6.3107	4.0500	1.5830	5.8744	2.4911	2.5548	5.7465	1.0951	5.7489	3.0759	1.4852	2.0759	1.8307	3.4305	3.6396	1.3946	2.5715	3.2840	1.6187	3.7016	1.2975	2.7723	6.4726	8.8886	5.7431	2.5499	2.9808	1.3231	3.1874	3.9017	6.4847	1.9399	2.2889	1.3875	1.9339	1.8734	1.6095	6.6277	3.5135	2.0247	1.0461	1.9860	1.6398	2.8076	0.9766	4.6054	3.6241	2.3176	3.7928	0.8477	4.7457	3.0007	2.6388	2.3711	2.6767	3.9951	2.9299	1.3973	2.5399	2.2460	2.2429	3.8554	4.0799	1.1314	2.4199	9.2188	7.5248	5.2295	3.3800	2.2877	2.0506	3.7500	1.5990
CH2_TG2	6.8823	1.9790	1.4219	2.6743	1.3304	1.2053	2.2931	5.9211	2.8167	3.1197	1.0327	1.2574	1.2806	5.5974	3.4702	1.0706	5.3732	1.9948	2.0870	5.1509	0.6410	4.8030	2.5401	0.9834	0.9637	1.3515	2.9244	3.0601	0.8934	2.1246	2.8866	1.1313	3.0863	0.8571	2.3622	6.0988	8.1568	4.9959	2.1304	2.6561	1.0808	3.3147	4.0886	5.5581	1.6544	1.7285	0.9779	1.5957	1.4889	1.3606	5.9433	2.9120	1.6131	0.7241	1.4910	1.2151	2.4925	0.6175	4.3443	3.1091	1.9557	3.2540	0.6149	3.9147	2.5312	2.0734	1.2613	2.1397	3.4408	3.2307	1.0722	2.1239	1.7576	2.0227	3.1981	3.4511	0.7426	1.6482	8.5459	6.8593	4.3147	2.8453	1.6821	1.5447	3.1750	1.0328
CH3-protons	81.6645	34.2527	45.6882	42.0833	27.9534	46.3592	41.8656	73.3472	63.7815	47.9284	33.9417	46.2318	42.4719	62.4818	56.2703	34.4179	64.1124	37.9219	35.1811	70.8146	27.4077	100.0877	52.4765	38.5311	80.4220	49.0521	51.5867	38.9721	42.9439	39.2139	46.7184	33.5147	63.4220	43.3069	65.9347	60.7888	77.5393	75.8922	28.5703	47.2386	29.1573	58.2614	70.1349	98.0347	37.3348	50.0666	44.0405	31.9112	34.5495	27.3143	66.9250	78.0869	51.3603	33.2380	45.1676	40.1999	41.6847	28.4650	57.8358	53.1888	37.8926	67.6441	22.4097	80.0309	48.5077	45.4227	85.3418	59.1992	57.8295	40.9334	44.9836	37.1294	41.2698	55.0717	68.1385	57.3046	40.4929	77.6259	75.0521	66.7341	52.6935	40.3537	31.4094	30.2260	60.6123	45.4370
CH=CH	39.9037	15.5458	19.2004	17.7205	10.9465	15.2031	18.8810	35.3527	26.8735	20.3544	13.9883	18.2003	14.9559	29.3905	26.6896	13.7157	29.0397	16.8168	15.3839	31.3061	9.6237	43.2060	21.2006	14.4797	31.2960	19.8387	23.6834	17.4047	14.9325	15.9128	18.7531	12.0124	26.4300	14.7342	26.0388	28.1428	39.9233	36.8393	13.5230	23.3212	10.5735	25.8262	32.1453	47.9894	17.1352	20.2303	17.4636	14.0124	13.4524	12.1907	37.1195	31.5039	21.6007	12.0648	17.2910	13.4032	18.8452	10.0540	24.7247	23.6493	16.4317	28.8201	7.7475	34.3864	19.8480	13.2165	27.7814	22.6563	27.7948	17.9318	16.2640	16.2026	16.9643	19.8460	29.2179	27.8588	14.9346	31.7782	40.8758	36.8610	22.0489	18.9734	11.0284	11.8593	27.4919	17.9247
CH-CH2-CH=CH	17.5334	6.6576	8.3885	6.8526	5.0829	5.1890	8.9848	14.7404	11.9813	8.7117	6.7066	8.1081	5.7521	13.6542	12.1829	6.0763	12.2010	8.1282	7.4082	13.1237	4.2740	18.1807	9.3435	6.0976	13.5841	9.1547	10.9556	7.1665	6.6889	6.3836	7.0156	4.6928	11.7664	6.5236	10.9274	10.2901	17.3969	15.9787	5.6171	11.3164	4.7750	11.4322	14.2040	22.4548	8.4136	8.8873	7.8812	6.5364	5.4689	5.5599	17.1022	14.0809	9.9605	4.9068	7.5764	5.7548	9.6264	4.1998	8.7658	10.1604	7.5905	11.3707	3.6536	14.2883	7.8352	4.3243	10.8246	9.4935	12.6415	8.4729	6.1392	6.3800	7.1752	8.4144	12.4819	12.1200	6.7672	14.0584	16.4015	15.2951	9.8351	7.8700	5.4755	4.7066	12.7742	8.0383
Cholesterol	33.1568	14.0587	22.4388	18.0186	12.7909	22.5799	17.8573	27.6469	28.9926	19.3026	16.1034	22.0621	20.5345	21.3411	22.8280	15.8653	22.3553	16.2081	14.7927	28.0888	13.6144	44.8911	22.8324	18.3192	39.1927	24.0108	22.5980	14.1076	21.9279	16.6881	19.2575	16.2490	27.7094	22.4722	31.4611	20.5754	24.3792	30.2012	10.7082	20.4978	13.8301	26.3467	30.1550	41.6390	16.5399	23.6517	22.0287	13.5773	15.1055	11.6862	23.2496	36.4624	24.1081	16.4025	21.3234	19.4491	18.1551	13.8372	21.6975	21.8758	15.9278	29.9980	11.1248	34.7543	20.6016	20.2078	42.4869	27.7185	24.1132	19.6297	22.4720	15.2078	18.6529	28.1923	30.0331	22.7607	20.5318	38.5327	21.4272	21.0328	18.4545	14.8444	14.1477	13.3043	26.8558	22.3595
CH phospholipid	1.4039	0.4170	0.7419	0.3864	0.4168	0.5022	0.8365	1.4236	1.1300	0.8223	0.4799	0.8275	0.5178	1.1153	0.9422	0.5335	1.5234	0.5207	0.4570	0.9771	0.2123	1.7146	0.8936	0.6515	2.0114	0.7915	0.8745	0.4423	0.3532	0.2730	0.4347	0.1623	1.1034	0.7346	0.7936	0.6853	1.2515	1.1578	0.5262	0.9016	0.3087	0.9527	1.4713	1.4173	0.6554	1.0292	0.8905	0.4870	0.3175	0.3488	1.3057	1.3299	1.1914	0.4652	0.8475	0.5630	0.6967	0.1800	0.7980	0.9410	0.4496	0.5127	0.2567	1.6251	0.6334	0.5331	1.8091	1.0326	1.0072	1.0699	0.5755	0.4273	0.5525	0.6880	1.1016	1.0840	0.6835	1.1591	1.4863	1.0513	0.3925	0.8672	0.3118	0.1940	0.8779	0.8799
CH TG	3.0385	1.1999	0.7198	1.2380	0.6512	0.8745	1.4195	3.0435	1.7634	1.6279	0.7714	0.8988	0.6728	3.2246	2.0222	0.8018	2.8013	1.3088	1.3859	2.8656	0.5846	2.6973	1.4346	0.6544	0.5194	0.8214	1.8344	1.9256	0.7254	1.3578	1.6229	0.8452	1.7519	0.5332	1.2507	3.2657	4.5954	2.7885	1.4385	1.4385	0.6329	1.5570	1.8304	3.0902	0.9156	1.0199	0.6043	0.9323	0.9107	0.8508	3.2862	1.6052	0.8851	0.5135	0.9121	0.7760	1.4621	0.5186	2.1657	1.8171	1.1749	1.8091	0.4580	2.2157	1.4718	1.2715	0.7262	1.1747	1.9360	1.4531	0.6045	1.3089	1.1647	1.0533	1.9137	2.0365	0.4302	1.0536	4.6779	3.8384	2.5692	1.6799	1.1355	1.0702	1.9427	0.7662
N+CH33 Pdt	6.8875	3.3902	4.2256	2.5036	1.9501	4.5687	5.3025	7.8565	6.6753	4.7211	4.6666	6.3049	3.6323	7.1489	6.3064	5.4866	7.6648	4.8891	3.2520	6.1172	2.4494	10.2145	5.8075	5.1727	14.6457	5.9752	5.4821	3.7519	2.8609	3.5801	3.6306	1.8934	7.2668	3.4943	4.6061	3.9474	7.3677	6.9604	2.1171	4.9750	1.7134	5.1478	8.3361	8.4102	3.0086	5.3939	4.7165	3.0506	2.8305	2.3934	6.7396	7.4916	6.1766	2.8365	4.3753	2.7425	2.3413	1.8972	5.0558	5.4201	3.0753	4.3006	1.7296	9.1050	3.9868	3.9357	10.8301	5.8521	4.8159	4.5678	3.2308	3.1467	3.3650	2.6274	5.6722	5.2921	4.1354	7.9031	6.6397	5.3542	1.7734	4.6536	1.2882	0.8736	4.3023	4.1814
N+CH33 SM	3.1046	1.1534	1.9524	1.4517	1.5486	1.7667	1.9020	3.0655	2.8330	2.5314	1.4368	2.3233	1.9061	1.9663	1.9758	1.4154	3.3327	1.2869	1.4643	1.8537	1.0983	3.2685	2.4667	1.7473	3.1942	2.0540	1.9986	1.4390	1.4400	0.7878	1.2171	0.7731	2.0759	2.5774	2.5044	1.2120	2.2484	2.4855	1.3675	1.7909	1.2217	2.5565	3.0792	3.2257	2.2970	2.3652	1.9822	1.5799	1.4048	0.9502	2.1336	3.3611	2.5976	1.5861	2.3665	2.1400	1.9136	0.9902	2.0142	1.7387	1.3736	1.6524	0.9440	2.9941	1.6620	2.5621	5.1222	2.4702	2.9979	2.4949	2.2015	1.2787	1.8635	2.4718	2.8381	2.5975	1.9468	2.7468	2.9014	2.1601	2.7200	2.2495	1.7454	0.7245	2.7424	2.6389
NMR_METABOLITE_DATA_END
#METABOLITES
METABOLITES_START
metabolite_name	pubchem_id	inchi_key	kegg_id	other_id	other_id_type	ri	ri_type	moverz_quant	
1CH phospholipids+TG									
C18-CH3 chol									
C19-CH3 Esterified Chol									
C19-CH3 free Chol									
CH2CH2CH2(CH2)-fatty acyl chains									
CH2-CH=CH-CH2-alpha18:1									
CH2-CH=CH-CH2-alpha18:2or20:4									
CH2COO-alpha									
CH2n aliphatic chains									
CH2_TG1									
CH2_TG2									
CH3-protons									
CH=CH									
CH-CH2-CH=CH									
Cholesterol									
CH phospholipid									
CH TG									
N+CH33 Pdt									
N+CH33 SM									
METABOLITES_END
#END